(Q63843468)
Statements
A Double Blind, Randomised, Parallel Group, Placebo Controlled Study of Sativex in the Treatment of Central Neuropathic Pain in Multiple Sclerosis. (English)
0 references
March 2002
0 references
August 2002
0 references
66
0 references
18 year
0 references